Novel immunotherapeutics against LGR5 to target multiple cancer types (vol 16, pg 2233, 2024)EMBO MOLECULAR MEDICINEIF8.32024-09-251OAAI
Novel immunotherapeutics against LGR5 to target multiple cancer typesEMBO MOLECULAR MEDICINEIF8.32024-08-211PRE
C1q/MASP Complexes-Hybrid Complexes of Classical and Lectin Pathway Proteins Are Found in the CirculationJOURNAL OF IMMUNOLOGYIF3.42024-08-090OA
Transient Binding Dynamics of Complement System Pattern Recognition Molecules on PathogensJOURNAL OF IMMUNOLOGYIF3.42024-03-150PRE
Mannan-binding lectin serine protease-2 (MASP-2) in human kidney and its relevance for proteolytic activation of the epithelial sodium channelSCIENTIFIC REPORTSIF3.92022-09-240OAAI
Cell-autonomous Hedgehog signaling controls Th17 polarization and pathogenicityNATURE COMMUNICATIONSIF15.72022-07-1413OAAI
SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven InflammationFRONTIERS IN IMMUNOLOGYIF5.92021-11-0243OAAI
Reply to Lassauniere: On the functional characterization of the Y453F RBD variant found in cluster 5 SARS-CoV-2JOURNAL OF BIOLOGICAL CHEMISTRYIF3.92021-11-011OAAI
Functional Effects of Receptor-Binding Domain Mutations of SARS-CoV-2 B.1.351 and P.1 VariantsFRONTIERS IN IMMUNOLOGYIF5.92021-10-0719OAAI
Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 primingJOURNAL OF INTERNAL MEDICINEIF9.22021-08-0218OAAI
SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding DomainJOURNAL OF IMMUNOLOGYIF3.42021-08-0132OA
SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent IndividualsJOURNAL OF IMMUNOLOGYIF3.42021-01-0190OAAI
The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralizationJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92021-01-0177OAAI
Combining MAP-1:CD35 or MAP-1:CD55 fusion proteins with pattern-recognition molecules as novel targeted modulators of the complement cascadeFASEB JOURNALIF4.22019-08-307OAAI
Alpha-cyclodextrin inhibits cholesterol crystal-induced complement-mediated inflammation: A potential new compound for treatment of atherosclerosisATHEROSCLEROSISIF5.72019-04-0124OAAI
Expression and characterization of MAP-1 containing fusion proteins regulating the complement cascadeMOLECULAR IMMUNOLOGYIF32018-10-010PREAI
Chimeric proteins containing MAP-1 and functional domains of C4b-binding protein reveal strong complement inhibitory capacitiesMOLECULAR IMMUNOLOGYIF32018-10-010OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向